Research programme: skin disorders therapeutics - Switch Biotech

Drug Profile

Research programme: skin disorders therapeutics - Switch Biotech

Alternative Names: Skin disorders therapeutics - Switch Biotech; SWT 01113; SWT 05141

Latest Information Update: 13 Jun 2016

Price : $50

At a glance

  • Originator SWITCH Biotech
  • Class Skin disorder therapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Alopecia; Atopic dermatitis; Psoriasis
  • Research Acne vulgaris; Actinic keratosis; Onychomycosis; Skin ulcer; Vitiligo

Most Recent Events

  • 09 Jun 2016 Early research in Acne vulgaris in USA (Topical) (Switch Biotech website, June 2016)
  • 09 Jun 2016 Early research in Actinic keratosis in USA (Topical) (Switch Biotech website, June 2016)
  • 09 Jun 2016 Early research in Onychomycosis (Nail fungus) in USA (Topical) (Switch Biotech website, June 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top